|
|
|
|
New Analysis Assesses Impact of Common Genetic Variation on Benefit of Antiplatelet Therapy
More than one out of four patients in analysis had variant in ABCB1 gene PARSIPPANY, N.J.and INDIANAPOLIS, March 15 /PRNewswire-FirstCall/ -- A new analysis of the TRITON-TIMI 38 study evaluated response rates in patients with a common genetic variant in the...
|
|
|
A Brave Young Woman with Breast Cancer
http://www.giveforward.org/teamnicole/So often in life, we look at issues such as a higher than usual electric bill, or a difficult co-worker, and think 'This is such a royal pain.' Sure, it hurts to have to fork out more money for utility bills, or to deal...
|
|
|
Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD
Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices (LVADs) may...
|
|
|
Cedars-Sinai Heart Institute Physicians Present Findings At American College Of Cardiology Scientific Meeting
Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices (LVADs) may...
|
|
|
Aspirin might help save breast cancer patients
I saw this item in the Washington Post while I was on leave and starred it to post here when I came back: Aspirin might play a role in beating breast cancer.The findings come from observations of the 4,164 breast cancer patients in the Nurses' Health...
|
|
|
Aspirin-like Drug Could Help Control Diabetes
(PhysOrg.com) -- Researchers at Tulane University School of Medicine are participating in a national study testing the ability of a generic drug called salsalate to control diabetes.The multi-site study is led by the Joslin Diabetes Center, Boston, with 17...
|
|
|
Better survival with ticagrelor vs. clopidogrel in PLATO analysis
American College of Cardiology 59th Annual Scientific Session ATLANTA Patient with acute coronary syndromes who undergo CABG surgery are less likely to develop fatal outcomes when given ticagrelor, a reversible, more intense P2Y12 receptor antagonist, instead...
|
|
|
Ticagrelor Shows Lower Mortality Than Clopidogrel After CABG
New Results from PLATO trial suggest ticagrelor (Brilinta) leads to lower mortality and no increased risk of bleeding when compared to clopidogrel (Plavix) in patients with acute coronary syndrome who undergo coronary artery bypass graft (CABG) surgery.
|
|
|
To Continue or Discontinue Aspirin in the Perioperative Period: A Randomized, Controlled Clinical Trial
In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.To find out how to adjust your browser settings to accept cookies, please click here. Medscape uses cookies to customize the site based on the information...
|
|
|
Genetic variations influence statin efficacy for lowering colon cancer risk
Four years ago, at least five years of statin use was found to be associated with a 53% reduction in the risk of colorectal cancer and that association still stands, according to a coauthor of one of the initial studies to make the statin-cancer connection.
|
|
|
How sumatriptan transformed the lives of millions of migraine sufferers
In our latest article on landmark drugs, Jenny Bryan looks at how the discovery of sumatriptan started a revolution in migraine treatment When Glaxo subsidiary Allen & Hanburys initiated a programme of migraine research in 1972,1 it would not have...
|
|
|
Medical News: Cedars-Sinai Heart Institute Physicians Present Findings At American College Of Cardiology Scientific Meeting
Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices (LVADs) may...
|
|
|
Antithrombotics Market Forecast - New Market Report Published
New report provides detailed analysis of the Healthcare and Medical market Published on March 19, 2010by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND IntroductionThe antithrombotics market, comprising anticoagulant and antiplatelet...
|
|
|
From Our Alliance: ACCP
ACCP celebrates 75 years with a look at telemedicine's increasing role View Comments (0)Print Articl Facebookreddit Newsvine Del.icio.us Digg Yahoo!BuzzLinkedIn StumbleUpon Google Bookmarks Mixx The start of the American College of Chest Physicians' 75th...
|
|
|
Arthritis Drug May Fight Diabetes, Too
MONDAY, March 15 (HealthDay News) -- A generic drug widely prescribed for arthritis shows promise in treating type 2 diabetes, according to U.S.researchers. They found that salsalate -- an atypical non-steroidal anti-inflammatory drug, chemically similar...
|
|
|
Treatment methods for the different types of psoriasis
abortion, accupuncture, ACE inhibitors, acne, ADHD, alcohol, allergies, Alzheimer's, anaemia, anaethesia, anorexia, antibiotics, antidepressants, antihistamine, anxiety, appetite control, arthritis, ASCOT, aspirin, asthma, atherosclerosis, autism,...
|
|
|
TopAbstracts in Pain 03/18/2010
TopAbstracts in Pain are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 7 days.Over 2000 peer-reviewed journals are covered by...
|
|
|
Cedars-Sinai Heart Institute Physicians Present Findings at American College of Cardiology Scientific Meeting
Source: Cedars-Sinai Medical Center Newswise Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the...
|
|
|
Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting
LOS ANGELES Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices...
|
|
|
Allergic To Aspirin, Penicillin, Other Medicines? Montefiore Program Helps Patients With Adverse Drug Reactions
A Westchester patient takes aspirin for pain, but develops rashes and hives.A Bronx patient with a gastrointestinal problem caused by bacteria is prescribed penicillin, then passes out. A Bronx woman is given a contrast dye for an internal diagnostic...
|
|
|
Allergic to Aspirin, Penicillin, Other Medicines? Montefiore Program Helps Patients With Adverse Drug Reactions
NEW YORK, March 17 /PRNewswire-USNewswire/ -- A Westchester patient takes aspirin for pain, but develops rashes and hives.A Bronx patient with a gastrointestinal problem caused by bacteria is prescribed penicillin, then passes out. A Bronx woman is...
|
|
|
Proper Use of OTC Analgesics
A survey conducted by the National Council on Patient Education reports that an estimated 78% of individuals surveyed used OTC analgesics for the management of pain.1 Various OTC analgesics are frequently used for the treatment and management of headaches,...
|
|
|
'Hooker Earrings' Day for Cancer Patients
Laughter really can be the best medicine.Related Find a Local Doctor FOCUS: Nutrition Month! Photos PICTURE GALLERY: Famous Breast Cancer Survivors Video Stories Aspirin May Reduce Risk for Breast Cancer Survivors New Treatments Help Fight Breast...
|
|
|
Generic shows promise in aiding type 2 diabetes treatment
A relatively inexpensive drug that has been used to relieve arthritis pain could also help treat a growing health problem, the type 2 form of diabetes.Researchers at the have been conducting a clinical trial of salsalate and found that it significantly...
|
|
|
FDA warning: some patients cannot process Plavix
WASHINGTON (AP) - The Food and Drug Administration is adding its strongest warning to the label for Plavix, cautioning that some patients do not respond to the blockbuster blood thinner.The FDA said in a statement Friday that certain patients with a genetic...
|
